SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
H & M Hennes & Mauritz AB (publ) (HMRZF) trades at a trailing P/E of 2.6, forward P/E of 2.4. Trailing earnings yield is 39.06%, forward earnings yield 41.84%. PEG 0.50 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (2.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.50); earnings yield beats bond yields (39.06%).
- Forward P/E 2.4 (down from trailing 2.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.50 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 39.06% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 41.84% as earnings recover.
Overall SharesGrow Score: 71/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HMRZF
Valuation Multiples
P/E (TTM)2.6
Forward P/E2.4
PEG Ratio0.50
Forward PEG0.33
P/B Ratio0.00
P/S Ratio0.14
EV/EBITDA0.0
Per Share Data
EPS (TTM)$7.58
Forward EPS (Est.)$8.13
Book Value / Share$0.00
Revenue / Share$142.32
FCF / Share$0.00
Yields & Fair Value
Earnings Yield39.06%
Forward Earnings Yield41.84%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$11.26 |
$192.27B |
$18.64B |
9.7% |
| 2017 |
$9.78 |
$200B |
$16.18B |
8.1% |
| 2018 |
$7.64 |
$210.4B |
$12.65B |
6% |
| 2019 |
$8.12 |
$232.76B |
$13.44B |
5.8% |
| 2020 |
$0.75 |
$187.03B |
$1.24B |
0.7% |
| 2021 |
$6.65 |
$198.97B |
$11.01B |
5.5% |
| 2022 |
$2.16 |
$223.55B |
$3.57B |
1.6% |
| 2023 |
$5.37 |
$236.04B |
$8.75B |
3.7% |
| 2024 |
$7.21 |
$234.48B |
$11.62B |
5% |
| 2025 |
$7.58 |
$228.29B |
$12.16B |
5.3% |
